Study | Study period | n | cCR | Locoregional treatment | 5-year overall survival | 5-year LRR | |||
---|---|---|---|---|---|---|---|---|---|
 |  |  |  | Surgery | RT alone | Surgery (%) | RT alone (%) | Surgery (%) | RT alone (%) |
De Lena et al. [11] | 1975–1980 prospective | 132 T3b-4 N0-2 | 100 % RT group; 60 % surgery group | 65 | 67 | 49.1a | 51.7a | 29.6 | 31.1 |
Perloff et al. [9] | 1978–1983 prospective | 87 | 18 % | 43 | 44 | 63b | 50b | 19 | 27 |
Scholl et al. [8] | 1986–1990 | 200 | ? | 36 Mtx ± RT, 62 BCS + RT | 102 | – | – | 24 |  |
Touboul et al. [6] | 1982–1990 prospective | 97 | 33 | 37 rD (>3 cm), Mtx; 27 rD (<3 cm), BCS | 33 | 83.3 | 75.7 | 16 after BCS, 5.4 after Mtx | 16 |
Ellis et al. [12] | 1985–1994 | 185 | 39 | 120; 29 Mtx, 91 BCS | 39 | 76 | 84 | 7 | 21 |
Mauriac et al. [7] | 1985–1989 | 134 T2-3 |  | 89; 40 BCS = RT, 49 Mtx | 44 | – | – | 22.5 BCS + RT, 22.4 after Mtx | 34 |
Ring et al. [13] | 1986–1999 | 453 | 136 | 67 | 69 | 74 | 76 | 10 | 21 |
Daveau et al. [10] | 1985–1999 | 1477 T2-3 | 165 | 65 | 100 | 82 | 91 | 12 | 23 |